Medibuddy UK против PLAB2App: PLAB2 Test Simulator Использование & Stats

Medibuddy is a medical education initiative which aims to make life easier for junior doctors applying for their training posts. The app allows you to access your Medibuddy interview and exam subscriptions.
  • Apple App Store
  • Бесплатный
  • Образование

Рейтинг магазина

- -

PLAB2App helps doctors to prepare for PLAB 2 (OSCE) exam. Most of examinees experience anxiety during the exam because of the unique and specific way this exam structured, our app will prepare you to the test and train you to shave precious seconds that usually gone because of confusion. The Professional and Linguistic Assessments Board test, or the PLAB test, helps GMC to make sure doctors who qualified abroad have the right knowledge and skills to practice medicine in the UK. PLAB 2 is an objective structured clinical exam (OSCE). It's made up of 16 scenarios, each lasting eight minutes and aims to reflect real life settings including a mock consultation or an acute ward. - You can make a mock station with real timer and real sounds from PLAB test to prepare you to the actual test environment. - You can add your questions (text or image) for the station. IMPORTANT: we are not affiliated with The General Medical Council in UK, this is just a tool to help doctors with the test, for support Please contact us at info@sp-apps.com Developed by: SP-Apps.com
  • Apple App Store
  • Бесплатный
  • Образование

Рейтинг магазина

- -

Medibuddy UK vs. PLAB2App: PLAB2 Test Simulator ranking comparison

Compare Medibuddy UK ranking trend in the past 28 days vs. PLAB2App: PLAB2 Test Simulator

Rank

Нет данных

Рейтинг Medibuddy UK против PLAB2App: PLAB2 Test Simulator в сравнении по странам

Сравните динамику рейтинга Medibuddy UK за последние 28 дней с динамикой рейтинга PLAB2App: PLAB2 Test Simulator.

Нет данных для отображения

Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией

Начать
Medibuddy UK VS.
PLAB2App: PLAB2 Test Simulator

декабрь 23, 2024